1. Home
  2. /
  3. ORTHOPEDICS

ORTHOPEDICS

Global
OPTIVISC

OPTIVISC

OPTIVISC is sterile viscoelastic gel having 20 mg of HA – 1% Concentration, indicated for use as an intra-articular injection.

OPTIVISC PLUS

OPTIVISC PLUS

OPTIVISC PLUS is sterile viscoelastic gel having 40 mg of HA – 2% Concentration, indicated for use as an intra-articular injection.

OPTIVISC M

OPTIVISC M

OPTIVISC M is sterile viscoelastic gel having 40 mg of HA – 2% Concentration + 0.5% Mannitol, indicated for use as an intra-articular injection.

OPTIVISC SINGLE

OPTIVISC SINGLE

OPTIVSC SINGLE is sterile viscoelastic gel having 60 mg and 90 mg Cross linked HA – 3% Concentration, indicated for use as an intra-articular injection.

BIOVISC ORTHO

BIOVISC ORTHO

BIOVISC ORTHO is sterile viscoelastic gel having 20 mg of HA – 1% Concentration, indicated for use as an intra-articular injection.

BIOVISC ORTHO PLUS

BIOVISC ORTHO PLUS

BIOVISC ORTHO PLUS is sterile viscoelastic gel having 40 mg of HA – 2% Concentration, indicated for use as an intra-articular injection.

BIOVISC ORTHO SINGLE

BIOVISC ORTHO SINGLE

BIOVISC ORTHO SINGLE is sterile viscoelastic gel having 40 mg of HA – 2% Concentration + 0.5% Mannitol, indicated for use as an intra-articular injection.

BIOVISC ORTHO M

BIOVISC ORTHO M

BIOVISC ORTHO M is sterile viscoelastic gel having 60 mg and 90 mg Cross linked HA – 3% Concentration, indicated for use as an intra-articular injection.

Biotech Vision Care Pvt. Ltd. (India)
BIOVISC ORTHO

BIOVISC ORTHO

BIOVISC ORTHO is sterile viscoelastic gel having 20 mg of HA – 1% Concentration, indicated for use as an intra-articular injection.

BIOVISC ORTHO PLUS

BIOVISC ORTHO PLUS

BIOVISC ORTHO PLUS is sterile viscoelastic gel having 40 mg of HA – 2% Concentration, indicated for use as an intra-articular injection.

BIOVISC ORTHO SINGLE

BIOVISC ORTHO SINGLE

BIOVISC ORTHO SINGLE is sterile viscoelastic gel having 40 mg of HA – 2% Concentration + 0.5% Mannitol, indicated for use as an intra-articular injection.

BIOVISC ORTHO M

BIOVISC ORTHO M

BIOVISC ORTHO M is sterile viscoelastic gel having 60 mg and 90 mg Cross linked HA – 3% Concentration, indicated for use as an intra-articular injection.

Biotech Europe Meditech Inc. Ltd. (Ireland)
OPTIVISC

OPTIVISC

OPTIVISC is sterile viscoelastic gel having 20 mg of HA – 1% Concentration, indicated for use as an intra-articular injection.

OPTIVISC PLUS

OPTIVISC PLUS

OPTIVISC PLUS is sterile viscoelastic gel having 40 mg of HA – 2% Concentration, indicated for use as an intra-articular injection.

OPTIVISC M

OPTIVISC M

OPTIVISC M is sterile viscoelastic gel having 40 mg of HA – 2% Concentration + 0.5% Mannitol, indicated for use as an intra-articular injection.

OPTIVISC SINGLE

OPTIVISC SINGLE

OPTIVSC SINGLE is sterile viscoelastic gel having 60 mg and 90 mg Cross linked HA – 3% Concentration, indicated for use as an intra-articular injection.

WHAT DO USERS SAY

“Optivisc benefit seems to me from ,practical point of view, is ease of injectability with  an acceptable viscosity & it is well tolerated by the patient. The patient feedback also is very good as they are aware that it gives them good analgesic action & also has preventive action in evolution of Arthrosis”

Dr. Henrique JonesPortugal

“I have used Optivisc in hip joint for last 5 years & for many many years in Knee Joint. Patient get benefitted in terms of reduced pain & better mobility for almost one year, which is very good”

Prof. Zlatko TemelkovskiMacedonia

“My main indication of using Biovisc Single is Post Operative especially in Ligament Surgery as well as that of Ankle. The other indication for using Biovisc Single is Frozen Shoulders. I have used in more than 50 patients & have seen that amount of stiffness is less & healing is better . It is Chondro-protective as well”

Dr. Preetesh ShahIndia

“I have used Optivisc 90 mg. as Single Shot Injection in 2nd & Early 3rd Stage of  Osteoarthritis patients & it has shown good results by improving the mobility & relieving Pain in 3 weeks after Injection”

Dr. Abd El – AlimEgypt

“I have been using Biotech’s single-shot viscosupplement solution in my grade II and early grade III osteoarthritis patients.  It takes usually couple of weeks for the solution to work. My patients report very good improvement in mobility and pain relief with the same.”

Dr. Ateet SharmaIndia
OPTIVISC

OPTIVISC

OPTIVISC is sterile viscoelastic gel having 20 mg of HA – 1% Concentration, indicated for use as an intra-articular injection.

FEATURES TECHNICAL SPECIFICATIONS BROCHURE PUBLICATIONS eIFU
OPTIVISC PLUS

OPTIVISC PLUS

OPTIVISC PLUS is sterile viscoelastic gel having 40 mg of HA – 2% Concentration, indicated for use as an intra-articular injection.

FEATURES TECHNICAL SPECIFICATIONS BROCHURE PUBLICATIONS eIFU
OPTIVISC M

OPTIVISC M

OPTIVISC M is sterile viscoelastic gel having 40 mg of HA – 2% Concentration + 0.5% Mannitol, indicated for use as an intra-articular injection.

FEATURES TECHNICAL SPECIFICATIONS BROCHURE PUBLICATIONS eIFU
OPTIVISC SINGLE

OPTIVISC SINGLE

OPTIVSC SINGLE is sterile viscoelastic gel having 60 mg and 90 mg Cross linked HA – 3% Concentration, indicated for use as an intra-articular injection.

FEATURES TECHNICAL SPECIFICATIONS BROCHURE PUBLICATIONS eIFU
BIOVISC ORTHO

BIOVISC ORTHO

BIOVISC ORTHO is sterile viscoelastic gel having 20 mg of HA – 1% Concentration, indicated for use as an intra-articular injection.

FEATURES TECHNICAL SPECIFICATIONS BROCHURE PUBLICATIONS eIFU
BIOVISC ORTHO PLUS

BIOVISC ORTHO PLUS

BIOVISC ORTHO PLUS is sterile viscoelastic gel having 40 mg of HA – 2% Concentration, indicated for use as an intra-articular injection.

FEATURES TECHNICAL SPECIFICATIONS BROCHURE PUBLICATIONS eIFU
BIOVISC ORTHO SINGLE

BIOVISC ORTHO SINGLE

BIOVISC ORTHO SINGLE is sterile viscoelastic gel having 40 mg of HA – 2% Concentration + 0.5% Mannitol, indicated for use as an intra-articular injection.

FEATURES TECHNICAL SPECIFICATIONS BROCHURE PUBLICATIONS eIFU
BIOVISC ORTHO M

BIOVISC ORTHO M

BIOVISC ORTHO M is sterile viscoelastic gel having 60 mg and 90 mg Cross linked HA – 3% Concentration, indicated for use as an intra-articular injection.

FEATURES TECHNICAL SPECIFICATIONS BROCHURE PUBLICATIONS eIFU

Battig Treuhand AG
Obergrundstrasse 17,
6002, Luzern,
Switzerland

CATEGORIES
CONTACT US
Biotech Health Care